Commonwealth Equity Services’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
NA
Commonwealth Equity Services's NVCR Position: Q3 2024 in Review
Commonwealth Equity Services sold out of NovoCure (NVCR) in Q3 2024, closing a stake of 10,463 shares — an estimated $179K sold.
Commonwealth Equity Services first reported a position in NVCR in Q4 2015 and held it in 18 quarters. The position peaked at $1.3M in Q4 2020. 224 funds tracked by Wall St. Rank hold NVCR as of Q3 2024.
- Commonwealth Equity Services reported no remaining NovoCure position as of Q3 2024 after selling out during the quarter.
- Commonwealth Equity Services sold 10,463 NovoCure shares in Q3 2024, an estimated $179K.
- Commonwealth Equity Services first reported a position in NovoCure in Q4 2015 and held it in 18 quarters.
- Commonwealth Equity Services's NovoCure position peaked at $1.3M in Q4 2020.
- 224 funds tracked by Wall St. Rank held NovoCure as of Q3 2024.
Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.